NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016

Transcription

1 33rd Annual Meeting NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016 Thursday-Friday, June 16-17, 2016 Conference Location: MEMORIAL SLOAN KETTERING CANCER CENTER Rockefeller Research Laboratories th Street, New York, NY, 10065

2 MSK sets a new standard for outpatient cancer surgery with the opening of the Josie Robertson Surgery Center. 33rd Annual Meeting NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016 The 33rd annual conference will provide National Corporate Medical Associates members with a comprehensive overview of treatment advances for cancer patients featuring a faculty of experts from MSK. You must be a National Corporate Medical Associates member to register for this activity. Course Directors William J. Schneider, MD, MPH Attending Physician in Medicine Memorial Sloan Kettering Cancer Center Stephen R. Veach, MD Attending Physician Thoracic Oncology Service Memorial Sloan Kettering Cancer Center Theodore J. Kowalski, MD Corporate Health Director of JP Morgan Chase & Co. External Liaison Director of the NCMA Registration for this event will be ed to all NCMA members. If you did not receive an , please contact cme@mskcc.org.

3 Thursday, June 16, :00-9:00am 9:00-9:05am 9:05-9:15am 9:15-9:45am 9:45-10:15am 10:15-10:45am 10:45-11:15am 11:15-11:30am 11:30-12:00pm 12:00-12:15pm 12:15-1:45pm 1:45-2:15pm 2:15-3:00pm 3:00-3:30pm 3:30-3:45pm 3:45-4:15pm 4:15-4:45pm 4:45-5:00pm BREAKFAST Introduction William J. Schneider, MD, MPH and Stephen R. Veach, MD Welcome Prostate Cancer Colon Cancer Screening Robin Mendelsohn, MD Immunologic Checkpoint Blockade: Exploring Combinations and Mechanisms Jedd D. Wolchok, MD, PhD Breast Cancer Radiation: New Indications Beryl McCormick, MD, FACR Exercise and Cancer Lee W. Jones, MD NCMA Developments PANEL: Reya Sinha, Theodore J. Kowalski, MD, Stephen Veach, MD and William J. Schneider, MD, MPH LUNCH SESSION Josie Robertson Surgical Center Brett A. Simon, MD, PhD Treatment of Actinic Keratoses: How My Patients Scare Away Children and Small Animals Allan C. Halpern, MD The Dilemma of Oncology Drug Costs Leonard B. Saltz, MD Infections with the Zika, Dengue and Chikungunya Viruses Monika K. Shah, MD MSK s Survivorship Program Stacie Corcoran, NP Developments in the Management of Multiple Myeloma Alexander M. Lesokhin, MD ANNOUNCEMENTS Registration for this event will be ed to all NCMA members. If you did not receive an , please contact cme@mskcc.org.

4 Friday, June 17, :00-9:00am 9:00-9:30am 9:30-10:00am 10:00-10:30am 10:30-10:45am 10:45-11:15am 11:15-11:45am 11:45-12:00pm BREAKFAST Developments in the Treatment of Lymphedema Babak J. Mehrara, MD Mitigating the Potential Side-Effects of Radiotherapy for G-U Cancer Marisa A. Kollmeier, MD What s New in Breast Cancer: ASCO Update, Triple Negative Breast Cancer and Beyond Tiffany A. Traina, MD Smoking Cessation Strategies Jack E. Burkhalter, MD What s New in Breast Cancer: ASCO Update, Endocrine therapy and HER2+ Maura Dickler, MD CONCLUSING COMMENTS Theodore J. Kowalski, MD NCMA physician members are invited to attend a special evening event on Thursday, June 16, 2016: 6:00pm - Dinner Playwright Celtic Pub & Restaurant 732 8th Avenue, New York, NY 8:00pm - CAGNEY the Musical Westside Theatre 407 W 43rd Street, New York, NY *Please note: Thursday evening events are reserved for NCMA physician members only. *Shuttle transportation will be provided to dinner only.

5 MSK Faculty Jack E. Burkhalter, PhD Psychologist Stacie Corcoran, NP Nurse Leader, Surviorship Clinic Maura Dickler, MD Associate Attending Physician Acting Service Chief, Breast Medicine Service Section Head, Endocrine Therapy Clinical Research Program Associate Professor, Weill Cornell Medicine Allan C. Halpern, MD Internist & Dermatologist; Chief, Dermatology Service Lee W. Jones, PhD Exercise Scientist Chair, Department of Medicine; George J. Bosl Chair Marisa A. Kollmeier, MD Radiation Oncologist Alexander M. Lesokhin, MD Hematologic Oncologist Beryl McCormick, MD, FACR Radiation Oncologist; Chief, External Beam Radiotherapy Service, Manhattan Babak J. Mehrara, MD Plastic & Reconstructive Surgery Robin Mendelsohn, MD Gastroenterologist Leonard B. Saltz, MD Medical Oncologist; Chief, Gastrointestinal Oncology Service; Head, Colorectal Oncology Section Monika K. Shah, MD Infectious Disease Specialist; Vice Chair, Education, Department of Medicine Brett A. Simon, MD, PhD Anesthesiologist; Director of MSK s Josie Roberston Surgery Center Reya Sinha Director, Office of the Physician-in-Chief Tiffany A. Traina, MD Associate Attending Physician Clinical Director, Breast Medicine Service Section Head, Triple Negative Breast Cancer Clinical Research Program Assistant Professor, Weill Cornell Medicine Jedd A. Wolchok, MD, PhD Lloyd J Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation; Chief, Melanoma & Immunotherapeutics Service; Associate Director, Ludgwig Center for Cancer Immunotherapy Registration Registration for this event will be ed to all NCMA members. If you did not receive an , please contact the office of Continuing Medical Education at cme@mskcc.org. Accreditation Statement MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA Credit Designation Statement MSK designates this live activity for a maximum of 9.0 AMA PRA Category 1 Credits TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 9.0 AMA PRA Category 1 Credit(s) TM. Accommodations For information on hotels in the area of MSK with discounted rates, please visit: Faculty Disclosure It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational. Evaluation A course evaluation survey sent out electronically will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs. Six months after the end of the course an Outcomes Measurement Survey will be sent to all participants to help us determine what positive impacts have been made on participant practice as a result of the course.